Key Points Microsoft introduced the Surface Laptop Ultra, a $2,599 laptop aimed at AI, video editing and gaming workloads. The device uses an Arm-based Nvidia RTX Spark processor and supports up to 128GB of unified memory. Microsoft positions it against Apple’s MacBook Pro and calls it its most powerful Surface yet. Microsoft claims faster AI…
Verastem, Inc. (NASDAQ: VSTM) shares gained about 6.4% to $8.25 on Wednesday, making it one of the top performers in the PRISM Women’s Health Index. The move comes one week before Verastem hosts an investor event on October 14. There it will present the first efficacy data for VS-7375, an oral drug that blocks KRAS…
Key Points Armata announced two issued U.S. patents covering treatment methods involving its investigational bacteriophage candidates, AP-SA02 and AP-PA02. The AP-SA02 patent was issued October 6, 2026, with expected protection until at least February 2041. The AP-PA02 patent was issued April 7, 2026, with expected protection until approximately January 4, 2043. Armata’s global portfolio now…
FuelCell Energy, Inc. (NASDAQ: FCEL), a clean energy technology company that manufactures utility-scale fuel cell power systems, is set to supply on-site power for a data center project that developer Fit Energy announced on October 6, 2026. Fit Energy plans to build the project in Newport Township in Luzerne County, Pennsylvania, on previously mined and…
Key Points Owlet launched a partnership with VillageFor to support new and expecting parents through pregnancy, postpartum and other paths to parenthood. Owlet360 members will receive three months of free VillagePlus access, including five “My Village” seats for trusted supporters. VillageFor members can receive a discount on Owlet products, subject to applicable terms. The partnership…
Wealthfront Corporation (NASDAQ: WLTH), a tech-driven financial platform built for digital natives, reported on October 6, 2026 its select monthly metrics for September. Total net deposits reached $532 million for the month, while total platform assets ended September at $100.5 billion, up 9% from a year earlier. Deposits Hold Steady Through a Rate Change September’s…
Key Points Neogen’s fiscal first-quarter revenue rose 6.5% to $222.8 million, with core growth of 8.1%. Adjusted EBITDA increased 17% to $41.6 million, and adjusted earnings per share doubled to $0.08. The company raised FY27 revenue guidance to $885 million–$890 million and adjusted EBITDA guidance to $181 million–$183 million. Validation of the first Petrifilm product…
Zura Bio Limited (NASDAQ: ZURA) shares rose about 9.5% to $4.34 on Wednesday, making it the top gainer in the PRISM Biotech Index. The move came as Merck presented positive Phase 2b data for its own HS treatment at the European Academy of Dermatology and Venereology (EADV) Congress. As a result, attention turned back to…
Biotricity Inc. (OTCQB: BTCY) shares rose 14.58% to approximately $0.06 as of mid day . Trading volume reached 90,060 shares, already about 25% above its average daily volume of 71,820 shares. The advance brought the company’s market capitalization to roughly $1.11 million, although the stock remained nearly 95% below its January 2, 2024, price of…
Clearmind Medicine Inc. (NASDAQ: CMND), a clinical-stage biopharmaceutical company developing non-hallucinogenic, psychedelic-derived neuroplastogens, announced on October 7, 2026 that it submitted recommendations to the U.S. Food and Drug Administration (FDA). The submission responds to the agency’s public hearing and request for comments on “Considerations for Potential Future Therapeutic Use of Psychedelic Drugs,” and focuses on…
The Navi Mumbai project lands in a market where several PRISM AI Datacenter & Infrastructure Index companies are building manufacturing, engineering and network capacity. CoreWeave (NASDAQ: CRWV) announced its entry into India on Wednesday with plans for 240 megawatts of AI data center capacity in Navi Mumbai through a collaboration with AdaniConneX. The campus will…
Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company developing oral therapeutics, announced on October 7, 2026 that Health Canada has approved TLANDO (testosterone undecanoate) capsules for testosterone replacement therapy (TRT) in adult males with hypogonadism. The approval came through licensing partner Verity Pharmaceuticals, which holds exclusive North American commercial rights to TLANDO and plans to…